nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Estradiol—osteoporosis	0.0405	0.144	CbGbCtD
Paliperidone—CYP3A4—Estropipate—osteoporosis	0.038	0.135	CbGbCtD
Paliperidone—CYP3A4—Calcitriol—osteoporosis	0.038	0.135	CbGbCtD
Paliperidone—CYP2D6—Cholecalciferol—osteoporosis	0.0308	0.11	CbGbCtD
Paliperidone—CYP3A4—Ergocalciferol—osteoporosis	0.0304	0.108	CbGbCtD
Paliperidone—CYP3A4—Raloxifene—osteoporosis	0.0254	0.0903	CbGbCtD
Paliperidone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0245	0.0872	CbGbCtD
Paliperidone—CYP3A4—Cholecalciferol—osteoporosis	0.0196	0.0697	CbGbCtD
Paliperidone—CYP3A4—Conjugated Estrogens—osteoporosis	0.018	0.064	CbGbCtD
Paliperidone—CYP3A4—Estradiol—osteoporosis	0.0158	0.0562	CbGbCtD
Paliperidone—Dry mouth—Zoledronate—osteoporosis	0.000269	0.000464	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000269	0.000464	CcSEcCtD
Paliperidone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000269	0.000463	CcSEcCtD
Paliperidone—Pruritus—Alendronate—osteoporosis	0.000268	0.000462	CcSEcCtD
Paliperidone—Dyspepsia—Risedronate—osteoporosis	0.000268	0.000461	CcSEcCtD
Paliperidone—Eye disorder—Estradiol—osteoporosis	0.000268	0.000461	CcSEcCtD
Paliperidone—Tinnitus—Estradiol—osteoporosis	0.000267	0.00046	CcSEcCtD
Paliperidone—Constipation—Ethinyl Estradiol—osteoporosis	0.000267	0.000459	CcSEcCtD
Paliperidone—Confusional state—Zoledronate—osteoporosis	0.000266	0.000459	CcSEcCtD
Paliperidone—Hypersensitivity—Calcitriol—osteoporosis	0.000266	0.000458	CcSEcCtD
Paliperidone—Flushing—Estradiol—osteoporosis	0.000266	0.000458	CcSEcCtD
Paliperidone—Cardiac disorder—Estradiol—osteoporosis	0.000266	0.000458	CcSEcCtD
Paliperidone—Chest pain—Conjugated Estrogens—osteoporosis	0.000265	0.000457	CcSEcCtD
Paliperidone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000265	0.000457	CcSEcCtD
Paliperidone—Myalgia—Conjugated Estrogens—osteoporosis	0.000265	0.000457	CcSEcCtD
Paliperidone—Asthenia—Ibandronate—osteoporosis	0.000265	0.000456	CcSEcCtD
Paliperidone—Anxiety—Conjugated Estrogens—osteoporosis	0.000264	0.000455	CcSEcCtD
Paliperidone—Nausea—Etidronic acid—osteoporosis	0.000264	0.000455	CcSEcCtD
Paliperidone—Anaphylactic shock—Zoledronate—osteoporosis	0.000264	0.000455	CcSEcCtD
Paliperidone—Oedema—Zoledronate—osteoporosis	0.000264	0.000455	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000263	0.000454	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000263	0.000454	CcSEcCtD
Paliperidone—Diarrhoea—Estropipate—osteoporosis	0.000263	0.000453	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000262	0.000452	CcSEcCtD
Paliperidone—Infection—Zoledronate—osteoporosis	0.000262	0.000452	CcSEcCtD
Paliperidone—Fatigue—Risedronate—osteoporosis	0.000262	0.000452	CcSEcCtD
Paliperidone—Insomnia—Pamidronate—osteoporosis	0.000261	0.00045	CcSEcCtD
Paliperidone—Pruritus—Ibandronate—osteoporosis	0.000261	0.00045	CcSEcCtD
Paliperidone—Pain—Risedronate—osteoporosis	0.00026	0.000448	CcSEcCtD
Paliperidone—Constipation—Risedronate—osteoporosis	0.00026	0.000448	CcSEcCtD
Paliperidone—Angiopathy—Estradiol—osteoporosis	0.00026	0.000448	CcSEcCtD
Paliperidone—Shock—Zoledronate—osteoporosis	0.00026	0.000447	CcSEcCtD
Paliperidone—Paraesthesia—Pamidronate—osteoporosis	0.00026	0.000447	CcSEcCtD
Paliperidone—Diarrhoea—Alendronate—osteoporosis	0.000259	0.000447	CcSEcCtD
Paliperidone—Asthenia—Calcitriol—osteoporosis	0.000259	0.000446	CcSEcCtD
Paliperidone—Nervous system disorder—Zoledronate—osteoporosis	0.000259	0.000446	CcSEcCtD
Paliperidone—Immune system disorder—Estradiol—osteoporosis	0.000259	0.000446	CcSEcCtD
Paliperidone—Thrombocytopenia—Zoledronate—osteoporosis	0.000258	0.000445	CcSEcCtD
Paliperidone—Mediastinal disorder—Estradiol—osteoporosis	0.000258	0.000445	CcSEcCtD
Paliperidone—Dyspnoea—Pamidronate—osteoporosis	0.000258	0.000444	CcSEcCtD
Paliperidone—Tachycardia—Zoledronate—osteoporosis	0.000258	0.000444	CcSEcCtD
Paliperidone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000257	0.000443	CcSEcCtD
Paliperidone—Chills—Estradiol—osteoporosis	0.000257	0.000443	CcSEcCtD
Paliperidone—Somnolence—Pamidronate—osteoporosis	0.000257	0.000443	CcSEcCtD
Paliperidone—Skin disorder—Zoledronate—osteoporosis	0.000256	0.000442	CcSEcCtD
Paliperidone—Pruritus—Calcitriol—osteoporosis	0.000256	0.00044	CcSEcCtD
Paliperidone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000255	0.000439	CcSEcCtD
Paliperidone—Diarrhoea—Raloxifene—osteoporosis	0.000255	0.000439	CcSEcCtD
Paliperidone—Dyspepsia—Pamidronate—osteoporosis	0.000254	0.000438	CcSEcCtD
Paliperidone—Dizziness—Estropipate—osteoporosis	0.000254	0.000438	CcSEcCtD
Paliperidone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000254	0.000438	CcSEcCtD
Paliperidone—Oedema—Conjugated Estrogens—osteoporosis	0.000254	0.000438	CcSEcCtD
Paliperidone—Alopecia—Estradiol—osteoporosis	0.000253	0.000436	CcSEcCtD
Paliperidone—Infection—Conjugated Estrogens—osteoporosis	0.000253	0.000435	CcSEcCtD
Paliperidone—Diarrhoea—Ibandronate—osteoporosis	0.000252	0.000435	CcSEcCtD
Paliperidone—Anorexia—Zoledronate—osteoporosis	0.000252	0.000434	CcSEcCtD
Paliperidone—Decreased appetite—Pamidronate—osteoporosis	0.000251	0.000433	CcSEcCtD
Paliperidone—Mental disorder—Estradiol—osteoporosis	0.000251	0.000432	CcSEcCtD
Paliperidone—Dizziness—Alendronate—osteoporosis	0.000251	0.000432	CcSEcCtD
Paliperidone—Shock—Conjugated Estrogens—osteoporosis	0.00025	0.000431	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00025	0.00043	CcSEcCtD
Paliperidone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000249	0.000429	CcSEcCtD
Paliperidone—Malnutrition—Estradiol—osteoporosis	0.000249	0.000429	CcSEcCtD
Paliperidone—Erythema—Estradiol—osteoporosis	0.000249	0.000429	CcSEcCtD
Paliperidone—Fatigue—Pamidronate—osteoporosis	0.000249	0.000429	CcSEcCtD
Paliperidone—Gastrointestinal pain—Risedronate—osteoporosis	0.000249	0.000428	CcSEcCtD
Paliperidone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000248	0.000427	CcSEcCtD
Paliperidone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000248	0.000427	CcSEcCtD
Paliperidone—Pain—Pamidronate—osteoporosis	0.000247	0.000426	CcSEcCtD
Paliperidone—Constipation—Pamidronate—osteoporosis	0.000247	0.000426	CcSEcCtD
Paliperidone—Diarrhoea—Calcitriol—osteoporosis	0.000247	0.000426	CcSEcCtD
Paliperidone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000247	0.000425	CcSEcCtD
Paliperidone—Hypotension—Zoledronate—osteoporosis	0.000247	0.000425	CcSEcCtD
Paliperidone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000247	0.000425	CcSEcCtD
Paliperidone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000247	0.000425	CcSEcCtD
Paliperidone—Dizziness—Raloxifene—osteoporosis	0.000246	0.000425	CcSEcCtD
Paliperidone—Flatulence—Estradiol—osteoporosis	0.000246	0.000423	CcSEcCtD
Paliperidone—Tension—Estradiol—osteoporosis	0.000245	0.000421	CcSEcCtD
Paliperidone—Vomiting—Estropipate—osteoporosis	0.000245	0.000421	CcSEcCtD
Paliperidone—Dysgeusia—Estradiol—osteoporosis	0.000244	0.000421	CcSEcCtD
Paliperidone—Dizziness—Ibandronate—osteoporosis	0.000244	0.00042	CcSEcCtD
Paliperidone—Rash—Estropipate—osteoporosis	0.000243	0.000418	CcSEcCtD
Paliperidone—Dermatitis—Estropipate—osteoporosis	0.000242	0.000418	CcSEcCtD
Paliperidone—Anorexia—Conjugated Estrogens—osteoporosis	0.000242	0.000417	CcSEcCtD
Paliperidone—Nervousness—Estradiol—osteoporosis	0.000242	0.000417	CcSEcCtD
Paliperidone—Urticaria—Risedronate—osteoporosis	0.000242	0.000416	CcSEcCtD
Paliperidone—Back pain—Estradiol—osteoporosis	0.000241	0.000415	CcSEcCtD
Paliperidone—Headache—Estropipate—osteoporosis	0.000241	0.000415	CcSEcCtD
Paliperidone—Vomiting—Alendronate—osteoporosis	0.000241	0.000415	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000241	0.000414	CcSEcCtD
Paliperidone—Abdominal pain—Risedronate—osteoporosis	0.00024	0.000414	CcSEcCtD
Paliperidone—Body temperature increased—Risedronate—osteoporosis	0.00024	0.000414	CcSEcCtD
Paliperidone—Muscle spasms—Estradiol—osteoporosis	0.00024	0.000413	CcSEcCtD
Paliperidone—Rash—Alendronate—osteoporosis	0.000239	0.000412	CcSEcCtD
Paliperidone—Insomnia—Zoledronate—osteoporosis	0.000239	0.000411	CcSEcCtD
Paliperidone—Dermatitis—Alendronate—osteoporosis	0.000239	0.000411	CcSEcCtD
Paliperidone—Feeling abnormal—Pamidronate—osteoporosis	0.000238	0.00041	CcSEcCtD
Paliperidone—Hypotension—Conjugated Estrogens—osteoporosis	0.000238	0.000409	CcSEcCtD
Paliperidone—Headache—Alendronate—osteoporosis	0.000237	0.000409	CcSEcCtD
Paliperidone—Paraesthesia—Zoledronate—osteoporosis	0.000237	0.000408	CcSEcCtD
Paliperidone—Vomiting—Raloxifene—osteoporosis	0.000237	0.000408	CcSEcCtD
Paliperidone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000236	0.000407	CcSEcCtD
Paliperidone—Dyspnoea—Zoledronate—osteoporosis	0.000235	0.000405	CcSEcCtD
Paliperidone—Rash—Raloxifene—osteoporosis	0.000235	0.000405	CcSEcCtD
Paliperidone—Dermatitis—Raloxifene—osteoporosis	0.000235	0.000404	CcSEcCtD
Paliperidone—Somnolence—Zoledronate—osteoporosis	0.000235	0.000404	CcSEcCtD
Paliperidone—Vomiting—Ibandronate—osteoporosis	0.000235	0.000404	CcSEcCtD
Paliperidone—Tremor—Estradiol—osteoporosis	0.000234	0.000402	CcSEcCtD
Paliperidone—Headache—Raloxifene—osteoporosis	0.000233	0.000402	CcSEcCtD
Paliperidone—Rash—Ibandronate—osteoporosis	0.000233	0.000401	CcSEcCtD
Paliperidone—Dermatitis—Ibandronate—osteoporosis	0.000232	0.0004	CcSEcCtD
Paliperidone—Dyspepsia—Zoledronate—osteoporosis	0.000232	0.0004	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000232	0.000399	CcSEcCtD
Paliperidone—Ill-defined disorder—Estradiol—osteoporosis	0.000231	0.000398	CcSEcCtD
Paliperidone—Headache—Ibandronate—osteoporosis	0.000231	0.000398	CcSEcCtD
Paliperidone—Insomnia—Conjugated Estrogens—osteoporosis	0.00023	0.000396	CcSEcCtD
Paliperidone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00023	0.000396	CcSEcCtD
Paliperidone—Vomiting—Calcitriol—osteoporosis	0.00023	0.000396	CcSEcCtD
Paliperidone—Decreased appetite—Zoledronate—osteoporosis	0.000229	0.000395	CcSEcCtD
Paliperidone—Agitation—Estradiol—osteoporosis	0.000229	0.000395	CcSEcCtD
Paliperidone—Nausea—Estropipate—osteoporosis	0.000229	0.000394	CcSEcCtD
Paliperidone—Body temperature increased—Pamidronate—osteoporosis	0.000228	0.000394	CcSEcCtD
Paliperidone—Abdominal pain—Pamidronate—osteoporosis	0.000228	0.000394	CcSEcCtD
Paliperidone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000228	0.000393	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000228	0.000393	CcSEcCtD
Paliperidone—Angioedema—Estradiol—osteoporosis	0.000228	0.000392	CcSEcCtD
Paliperidone—Rash—Calcitriol—osteoporosis	0.000228	0.000392	CcSEcCtD
Paliperidone—Fatigue—Zoledronate—osteoporosis	0.000228	0.000392	CcSEcCtD
Paliperidone—Dermatitis—Calcitriol—osteoporosis	0.000227	0.000392	CcSEcCtD
Paliperidone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000227	0.00039	CcSEcCtD
Paliperidone—Headache—Calcitriol—osteoporosis	0.000226	0.00039	CcSEcCtD
Paliperidone—Somnolence—Conjugated Estrogens—osteoporosis	0.000226	0.000389	CcSEcCtD
Paliperidone—Constipation—Zoledronate—osteoporosis	0.000226	0.000389	CcSEcCtD
Paliperidone—Pain—Zoledronate—osteoporosis	0.000226	0.000389	CcSEcCtD
Paliperidone—Nausea—Alendronate—osteoporosis	0.000225	0.000388	CcSEcCtD
Paliperidone—Malaise—Estradiol—osteoporosis	0.000225	0.000387	CcSEcCtD
Paliperidone—Hypersensitivity—Risedronate—osteoporosis	0.000224	0.000386	CcSEcCtD
Paliperidone—Vertigo—Estradiol—osteoporosis	0.000224	0.000386	CcSEcCtD
Paliperidone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000224	0.000385	CcSEcCtD
Paliperidone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000224	0.000385	CcSEcCtD
Paliperidone—Syncope—Estradiol—osteoporosis	0.000224	0.000385	CcSEcCtD
Paliperidone—Nausea—Raloxifene—osteoporosis	0.000221	0.000381	CcSEcCtD
Paliperidone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000221	0.000381	CcSEcCtD
Paliperidone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000221	0.00038	CcSEcCtD
Paliperidone—Palpitations—Estradiol—osteoporosis	0.00022	0.00038	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000219	0.000378	CcSEcCtD
Paliperidone—Fatigue—Conjugated Estrogens—osteoporosis	0.000219	0.000378	CcSEcCtD
Paliperidone—Nausea—Ibandronate—osteoporosis	0.000219	0.000378	CcSEcCtD
Paliperidone—Loss of consciousness—Estradiol—osteoporosis	0.000219	0.000377	CcSEcCtD
Paliperidone—Asthenia—Risedronate—osteoporosis	0.000218	0.000376	CcSEcCtD
Paliperidone—Feeling abnormal—Zoledronate—osteoporosis	0.000218	0.000375	CcSEcCtD
Paliperidone—Cough—Estradiol—osteoporosis	0.000218	0.000375	CcSEcCtD
Paliperidone—Constipation—Conjugated Estrogens—osteoporosis	0.000217	0.000375	CcSEcCtD
Paliperidone—Pain—Conjugated Estrogens—osteoporosis	0.000217	0.000375	CcSEcCtD
Paliperidone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000216	0.000372	CcSEcCtD
Paliperidone—Hypertension—Estradiol—osteoporosis	0.000215	0.000371	CcSEcCtD
Paliperidone—Pruritus—Risedronate—osteoporosis	0.000215	0.000371	CcSEcCtD
Paliperidone—Nausea—Calcitriol—osteoporosis	0.000215	0.00037	CcSEcCtD
Paliperidone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000213	0.000368	CcSEcCtD
Paliperidone—Hypersensitivity—Pamidronate—osteoporosis	0.000213	0.000367	CcSEcCtD
Paliperidone—Chest pain—Estradiol—osteoporosis	0.000212	0.000366	CcSEcCtD
Paliperidone—Myalgia—Estradiol—osteoporosis	0.000212	0.000366	CcSEcCtD
Paliperidone—Arthralgia—Estradiol—osteoporosis	0.000212	0.000366	CcSEcCtD
Paliperidone—Anxiety—Estradiol—osteoporosis	0.000211	0.000364	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000211	0.000363	CcSEcCtD
Paliperidone—Urticaria—Zoledronate—osteoporosis	0.00021	0.000361	CcSEcCtD
Paliperidone—Discomfort—Estradiol—osteoporosis	0.00021	0.000361	CcSEcCtD
Paliperidone—Abdominal pain—Zoledronate—osteoporosis	0.000209	0.00036	CcSEcCtD
Paliperidone—Body temperature increased—Zoledronate—osteoporosis	0.000209	0.00036	CcSEcCtD
Paliperidone—Diarrhoea—Risedronate—osteoporosis	0.000208	0.000358	CcSEcCtD
Paliperidone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000208	0.000358	CcSEcCtD
Paliperidone—Dry mouth—Estradiol—osteoporosis	0.000208	0.000358	CcSEcCtD
Paliperidone—Asthenia—Pamidronate—osteoporosis	0.000207	0.000357	CcSEcCtD
Paliperidone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000206	0.000355	CcSEcCtD
Paliperidone—Confusional state—Estradiol—osteoporosis	0.000205	0.000353	CcSEcCtD
Paliperidone—Pruritus—Pamidronate—osteoporosis	0.000204	0.000352	CcSEcCtD
Paliperidone—Oedema—Estradiol—osteoporosis	0.000203	0.00035	CcSEcCtD
Paliperidone—Anaphylactic shock—Estradiol—osteoporosis	0.000203	0.00035	CcSEcCtD
Paliperidone—Infection—Estradiol—osteoporosis	0.000202	0.000348	CcSEcCtD
Paliperidone—Urticaria—Conjugated Estrogens—osteoporosis	0.000202	0.000348	CcSEcCtD
Paliperidone—Dizziness—Risedronate—osteoporosis	0.000201	0.000346	CcSEcCtD
Paliperidone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000201	0.000346	CcSEcCtD
Paliperidone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000201	0.000346	CcSEcCtD
Paliperidone—Shock—Estradiol—osteoporosis	0.0002	0.000345	CcSEcCtD
Paliperidone—Nervous system disorder—Estradiol—osteoporosis	0.0002	0.000344	CcSEcCtD
Paliperidone—Tachycardia—Estradiol—osteoporosis	0.000199	0.000342	CcSEcCtD
Paliperidone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000198	0.000342	CcSEcCtD
Paliperidone—Diarrhoea—Pamidronate—osteoporosis	0.000198	0.000341	CcSEcCtD
Paliperidone—Skin disorder—Estradiol—osteoporosis	0.000198	0.00034	CcSEcCtD
Paliperidone—Rash—Ethinyl Estradiol—osteoporosis	0.000197	0.000339	CcSEcCtD
Paliperidone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000196	0.000338	CcSEcCtD
Paliperidone—Headache—Ethinyl Estradiol—osteoporosis	0.000195	0.000337	CcSEcCtD
Paliperidone—Hypersensitivity—Zoledronate—osteoporosis	0.000195	0.000335	CcSEcCtD
Paliperidone—Vomiting—Risedronate—osteoporosis	0.000193	0.000333	CcSEcCtD
Paliperidone—Rash—Risedronate—osteoporosis	0.000192	0.00033	CcSEcCtD
Paliperidone—Dermatitis—Risedronate—osteoporosis	0.000192	0.00033	CcSEcCtD
Paliperidone—Dizziness—Pamidronate—osteoporosis	0.000191	0.000329	CcSEcCtD
Paliperidone—Headache—Risedronate—osteoporosis	0.00019	0.000328	CcSEcCtD
Paliperidone—Asthenia—Zoledronate—osteoporosis	0.000189	0.000326	CcSEcCtD
Paliperidone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000187	0.000323	CcSEcCtD
Paliperidone—Pruritus—Zoledronate—osteoporosis	0.000187	0.000322	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000185	0.000319	CcSEcCtD
Paliperidone—Nausea—Ethinyl Estradiol—osteoporosis	0.000185	0.000319	CcSEcCtD
Paliperidone—Insomnia—Estradiol—osteoporosis	0.000184	0.000317	CcSEcCtD
Paliperidone—Vomiting—Pamidronate—osteoporosis	0.000184	0.000317	CcSEcCtD
Paliperidone—Paraesthesia—Estradiol—osteoporosis	0.000183	0.000315	CcSEcCtD
Paliperidone—Asthenia—Conjugated Estrogens—osteoporosis	0.000182	0.000314	CcSEcCtD
Paliperidone—Rash—Pamidronate—osteoporosis	0.000182	0.000314	CcSEcCtD
Paliperidone—Dermatitis—Pamidronate—osteoporosis	0.000182	0.000314	CcSEcCtD
Paliperidone—Dyspnoea—Estradiol—osteoporosis	0.000181	0.000312	CcSEcCtD
Paliperidone—Headache—Pamidronate—osteoporosis	0.000181	0.000312	CcSEcCtD
Paliperidone—Somnolence—Estradiol—osteoporosis	0.000181	0.000312	CcSEcCtD
Paliperidone—Diarrhoea—Zoledronate—osteoporosis	0.000181	0.000311	CcSEcCtD
Paliperidone—Nausea—Risedronate—osteoporosis	0.000181	0.000311	CcSEcCtD
Paliperidone—Pruritus—Conjugated Estrogens—osteoporosis	0.00018	0.00031	CcSEcCtD
Paliperidone—Dyspepsia—Estradiol—osteoporosis	0.000179	0.000309	CcSEcCtD
Paliperidone—Decreased appetite—Estradiol—osteoporosis	0.000177	0.000305	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000176	0.000303	CcSEcCtD
Paliperidone—Fatigue—Estradiol—osteoporosis	0.000175	0.000302	CcSEcCtD
Paliperidone—Dizziness—Zoledronate—osteoporosis	0.000175	0.000301	CcSEcCtD
Paliperidone—Pain—Estradiol—osteoporosis	0.000174	0.0003	CcSEcCtD
Paliperidone—Constipation—Estradiol—osteoporosis	0.000174	0.0003	CcSEcCtD
Paliperidone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000174	0.0003	CcSEcCtD
Paliperidone—Nausea—Pamidronate—osteoporosis	0.000172	0.000296	CcSEcCtD
Paliperidone—Dizziness—Conjugated Estrogens—osteoporosis	0.000168	0.00029	CcSEcCtD
Paliperidone—Vomiting—Zoledronate—osteoporosis	0.000168	0.000289	CcSEcCtD
Paliperidone—Feeling abnormal—Estradiol—osteoporosis	0.000168	0.000289	CcSEcCtD
Paliperidone—Rash—Zoledronate—osteoporosis	0.000166	0.000287	CcSEcCtD
Paliperidone—Gastrointestinal pain—Estradiol—osteoporosis	0.000166	0.000287	CcSEcCtD
Paliperidone—Dermatitis—Zoledronate—osteoporosis	0.000166	0.000287	CcSEcCtD
Paliperidone—Headache—Zoledronate—osteoporosis	0.000165	0.000285	CcSEcCtD
Paliperidone—Vomiting—Conjugated Estrogens—osteoporosis	0.000162	0.000278	CcSEcCtD
Paliperidone—Urticaria—Estradiol—osteoporosis	0.000162	0.000278	CcSEcCtD
Paliperidone—Abdominal pain—Estradiol—osteoporosis	0.000161	0.000277	CcSEcCtD
Paliperidone—Body temperature increased—Estradiol—osteoporosis	0.000161	0.000277	CcSEcCtD
Paliperidone—Rash—Conjugated Estrogens—osteoporosis	0.00016	0.000276	CcSEcCtD
Paliperidone—Dermatitis—Conjugated Estrogens—osteoporosis	0.00016	0.000276	CcSEcCtD
Paliperidone—Headache—Conjugated Estrogens—osteoporosis	0.000159	0.000274	CcSEcCtD
Paliperidone—Nausea—Zoledronate—osteoporosis	0.000157	0.00027	CcSEcCtD
Paliperidone—Nausea—Conjugated Estrogens—osteoporosis	0.000151	0.00026	CcSEcCtD
Paliperidone—Hypersensitivity—Estradiol—osteoporosis	0.00015	0.000258	CcSEcCtD
Paliperidone—Asthenia—Estradiol—osteoporosis	0.000146	0.000251	CcSEcCtD
Paliperidone—Pruritus—Estradiol—osteoporosis	0.000144	0.000248	CcSEcCtD
Paliperidone—Diarrhoea—Estradiol—osteoporosis	0.000139	0.00024	CcSEcCtD
Paliperidone—Dizziness—Estradiol—osteoporosis	0.000135	0.000232	CcSEcCtD
Paliperidone—Vomiting—Estradiol—osteoporosis	0.000129	0.000223	CcSEcCtD
Paliperidone—Rash—Estradiol—osteoporosis	0.000128	0.000221	CcSEcCtD
Paliperidone—Dermatitis—Estradiol—osteoporosis	0.000128	0.000221	CcSEcCtD
Paliperidone—Headache—Estradiol—osteoporosis	0.000127	0.00022	CcSEcCtD
Paliperidone—Nausea—Estradiol—osteoporosis	0.000121	0.000208	CcSEcCtD
Paliperidone—HRH1—GPCR downstream signaling—POMC—osteoporosis	2.65e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	2.64e-05	0.000191	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IRS2—osteoporosis	2.63e-05	0.00019	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MGLL—osteoporosis	2.62e-05	0.000189	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ADCY5—osteoporosis	2.61e-05	0.000189	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—RAP1A—osteoporosis	2.61e-05	0.000188	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	2.6e-05	0.000188	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ADCY5—osteoporosis	2.6e-05	0.000188	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.6e-05	0.000188	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—GPX1—osteoporosis	2.59e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.58e-05	0.000187	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IRS2—osteoporosis	2.58e-05	0.000186	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—LEP—osteoporosis	2.58e-05	0.000186	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ADCY5—osteoporosis	2.58e-05	0.000186	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IRS2—osteoporosis	2.54e-05	0.000183	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SPP1—osteoporosis	2.53e-05	0.000183	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—LEP—osteoporosis	2.52e-05	0.000182	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KL—osteoporosis	2.52e-05	0.000182	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SPP1—osteoporosis	2.49e-05	0.00018	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—LEP—osteoporosis	2.48e-05	0.00018	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.48e-05	0.000179	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KL—osteoporosis	2.48e-05	0.000179	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KL—osteoporosis	2.47e-05	0.000179	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—ESR1—osteoporosis	2.46e-05	0.000178	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—POMC—osteoporosis	2.46e-05	0.000177	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KL—osteoporosis	2.43e-05	0.000175	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2.42e-05	0.000175	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—POMC—osteoporosis	2.42e-05	0.000175	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—POMC—osteoporosis	2.41e-05	0.000174	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—ESR1—osteoporosis	2.41e-05	0.000174	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.4e-05	0.000173	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—MTHFR—osteoporosis	2.39e-05	0.000173	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—ESR1—osteoporosis	2.37e-05	0.000171	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CYP19A1—osteoporosis	2.37e-05	0.000171	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—POMC—osteoporosis	2.37e-05	0.000171	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.36e-05	0.00017	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6R—osteoporosis	2.35e-05	0.00017	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	2.33e-05	0.000168	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	2.31e-05	0.000167	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IRS1—osteoporosis	2.3e-05	0.000166	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IRS2—osteoporosis	2.29e-05	0.000165	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IRS2—osteoporosis	2.25e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KL—osteoporosis	2.25e-05	0.000163	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IRS1—osteoporosis	2.25e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SPP1—osteoporosis	2.25e-05	0.000163	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ADCY5—osteoporosis	2.25e-05	0.000162	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—LEP—osteoporosis	2.24e-05	0.000162	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ADCY5—osteoporosis	2.23e-05	0.000161	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—IDH2—osteoporosis	2.23e-05	0.000161	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IRS1—osteoporosis	2.22e-05	0.00016	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—POMC—osteoporosis	2.21e-05	0.00016	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TGFB1—osteoporosis	2.21e-05	0.00016	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—LEP—osteoporosis	2.21e-05	0.000159	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.2e-05	0.000159	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	2.17e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SPP1—osteoporosis	2.17e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—POMC—osteoporosis	2.17e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SPP1—osteoporosis	2.16e-05	0.000156	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6R—osteoporosis	2.16e-05	0.000156	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.14e-05	0.000155	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	2.14e-05	0.000155	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ESR1—osteoporosis	2.14e-05	0.000154	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—POMC—osteoporosis	2.13e-05	0.000154	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IGF1—osteoporosis	2.13e-05	0.000154	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6R—osteoporosis	2.12e-05	0.000153	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ADCY5—osteoporosis	2.11e-05	0.000153	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ESR1—osteoporosis	2.11e-05	0.000152	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ENO1—osteoporosis	2.11e-05	0.000152	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—GPX1—osteoporosis	2.1e-05	0.000152	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SPP1—osteoporosis	2.1e-05	0.000152	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.1e-05	0.000151	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IGF1—osteoporosis	2.09e-05	0.000151	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6R—osteoporosis	2.08e-05	0.00015	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PSMA2—osteoporosis	2.08e-05	0.00015	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PSMA5—osteoporosis	2.08e-05	0.00015	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SPP1—osteoporosis	2.07e-05	0.00015	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IGF1—osteoporosis	2.05e-05	0.000148	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ACP5—osteoporosis	2.04e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IRS2—osteoporosis	2.04e-05	0.000147	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IRS1—osteoporosis	1.99e-05	0.000144	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.99e-05	0.000144	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.97e-05	0.000143	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IRS1—osteoporosis	1.97e-05	0.000142	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.97e-05	0.000142	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.95e-05	0.000141	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—MTHFR—osteoporosis	1.94e-05	0.00014	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.94e-05	0.00014	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.94e-05	0.00014	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.93e-05	0.00014	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—GPX1—osteoporosis	1.93e-05	0.000139	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—LEP—osteoporosis	1.92e-05	0.000139	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—POMC—osteoporosis	1.92e-05	0.000139	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—LEP—osteoporosis	1.91e-05	0.000138	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—POMC—osteoporosis	1.91e-05	0.000138	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SPP1—osteoporosis	1.91e-05	0.000138	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.9e-05	0.000137	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.9e-05	0.000137	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.9e-05	0.000137	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—POMC—osteoporosis	1.9e-05	0.000137	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TPI1—osteoporosis	1.9e-05	0.000137	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.88e-05	0.000136	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6R—osteoporosis	1.87e-05	0.000135	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SPP1—osteoporosis	1.87e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.87e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000134	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6R—osteoporosis	1.85e-05	0.000134	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IGF1—osteoporosis	1.85e-05	0.000134	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.84e-05	0.000133	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.84e-05	0.000133	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.83e-05	0.000132	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.83e-05	0.000132	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IGF1—osteoporosis	1.82e-05	0.000132	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—P4HB—osteoporosis	1.78e-05	0.000129	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—MTHFR—osteoporosis	1.78e-05	0.000129	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.78e-05	0.000128	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.78e-05	0.000128	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.77e-05	0.000128	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.75e-05	0.000126	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.75e-05	0.000126	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IRS2—osteoporosis	1.73e-05	0.000125	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.72e-05	0.000124	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.71e-05	0.000124	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.71e-05	0.000123	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.71e-05	0.000123	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.7e-05	0.000123	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.7e-05	0.000123	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IRS2—osteoporosis	1.69e-05	0.000122	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—LEP—osteoporosis	1.69e-05	0.000122	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.68e-05	0.000122	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.67e-05	0.000121	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.66e-05	0.00012	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—LEP—osteoporosis	1.66e-05	0.00012	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.00012	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—LEP—osteoporosis	1.66e-05	0.00012	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—POMC—osteoporosis	1.65e-05	0.000119	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.65e-05	0.000119	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—POMC—osteoporosis	1.64e-05	0.000119	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.63e-05	0.000118	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.63e-05	0.000118	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.63e-05	0.000118	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ESR1—osteoporosis	1.61e-05	0.000116	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.61e-05	0.000116	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.6e-05	0.000115	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.59e-05	0.000115	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.59e-05	0.000115	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ESR1—osteoporosis	1.58e-05	0.000114	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.000114	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.57e-05	0.000114	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—osteoporosis	1.57e-05	0.000113	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.56e-05	0.000113	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.55e-05	0.000112	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—POMC—osteoporosis	1.55e-05	0.000112	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.54e-05	0.000112	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.54e-05	0.000111	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.53e-05	0.000111	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.51e-05	0.000109	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.51e-05	0.000109	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IRS1—osteoporosis	1.51e-05	0.000109	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.48e-05	0.000107	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IRS1—osteoporosis	1.48e-05	0.000107	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.45e-05	0.000105	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—POMC—osteoporosis	1.45e-05	0.000105	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.44e-05	0.000104	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—POMC—osteoporosis	1.43e-05	0.000103	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—POMC—osteoporosis	1.42e-05	0.000103	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—POMC—osteoporosis	1.42e-05	0.000103	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6R—osteoporosis	1.41e-05	0.000102	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—osteoporosis	1.41e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.4e-05	0.000101	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF1—osteoporosis	1.4e-05	0.000101	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—osteoporosis	1.39e-05	0.000101	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.39e-05	0.000101	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6R—osteoporosis	1.39e-05	0.0001	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ENO1—osteoporosis	1.38e-05	9.95e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ADCY5—osteoporosis	1.38e-05	9.94e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.37e-05	9.92e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GPX1—osteoporosis	1.37e-05	9.91e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF1—osteoporosis	1.37e-05	9.9e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.36e-05	9.85e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.36e-05	9.81e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.36e-05	9.81e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.35e-05	9.74e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.34e-05	9.71e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.3e-05	9.38e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MYC—osteoporosis	1.28e-05	9.25e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—osteoporosis	1.28e-05	9.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.27e-05	9.15e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MTHFR—osteoporosis	1.27e-05	9.14e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.26e-05	9.1e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MYC—osteoporosis	1.25e-05	9.06e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—osteoporosis	1.25e-05	9.04e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.25e-05	9.03e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MYC—osteoporosis	1.23e-05	8.91e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—osteoporosis	1.23e-05	8.89e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—osteoporosis	1.22e-05	8.78e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.21e-05	8.74e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.18e-05	8.5e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.16e-05	8.36e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MYC—osteoporosis	1.11e-05	8.03e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.11e-05	8.01e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.1e-05	7.96e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MYC—osteoporosis	1.1e-05	7.92e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—osteoporosis	1.09e-05	7.9e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—osteoporosis	1.07e-05	7.71e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—osteoporosis	1.05e-05	7.59e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—osteoporosis	1.05e-05	7.57e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—osteoporosis	1.03e-05	7.43e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—osteoporosis	1.01e-05	7.31e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MYC—osteoporosis	9.89e-06	7.15e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	9.87e-06	7.13e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—osteoporosis	9.62e-06	6.95e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—osteoporosis	9.55e-06	6.9e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MYC—osteoporosis	9.55e-06	6.9e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—osteoporosis	9.53e-06	6.88e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MYC—osteoporosis	9.5e-06	6.87e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—osteoporosis	9.48e-06	6.85e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—osteoporosis	9.42e-06	6.81e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—osteoporosis	9.27e-06	6.7e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MYC—osteoporosis	9.24e-06	6.68e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	9.22e-06	6.66e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MYC—osteoporosis	9.09e-06	6.57e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	9.07e-06	6.56e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ADCY5—osteoporosis	8.99e-06	6.5e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GPX1—osteoporosis	8.96e-06	6.48e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MYC—osteoporosis	8.38e-06	6.06e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—osteoporosis	8.36e-06	6.04e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—osteoporosis	8.35e-06	6.03e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—osteoporosis	8.27e-06	5.98e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MYC—osteoporosis	8.25e-06	5.96e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—osteoporosis	8.24e-06	5.95e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MYC—osteoporosis	8.23e-06	5.95e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—osteoporosis	8.23e-06	5.95e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—osteoporosis	8.21e-06	5.93e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MYC—osteoporosis	8.08e-06	5.84e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	8.06e-06	5.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MYC—osteoporosis	7.51e-06	5.42e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	7.49e-06	5.41e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—osteoporosis	7.44e-06	5.37e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—osteoporosis	7.18e-06	5.19e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—osteoporosis	7.14e-06	5.16e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—osteoporosis	6.95e-06	5.02e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—osteoporosis	6.84e-06	4.94e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—osteoporosis	6.62e-06	4.78e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—osteoporosis	6.3e-06	4.55e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—osteoporosis	6.2e-06	4.48e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—osteoporosis	6.19e-06	4.47e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—osteoporosis	6.07e-06	4.39e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—osteoporosis	5.64e-06	4.08e-05	CbGpPWpGaD
